ArticleKorean journal of radiology2026

Radiologic Response Assessment With RECIST 1.1 and mRECIST in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Boryeong Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.